Advanced or Metastatic Gastrointestinal Stromal Tumors: Systemic Treatment Options

被引:22
作者
Caram, Megan V. [1 ]
Schuetze, Scott M. [1 ]
机构
[1] Univ Michigan, Div Hematol Oncol, Dept Internal Med, Ann Arbor, MI 48109 USA
关键词
GIST; imatinib; sunitinib; OF-FUNCTION MUTATIONS; PHASE-II TRIAL; IMATINIB MESYLATE; TYROSINE KINASE; SURGICAL RESECTION; DOSE IMATINIB; GIST; SARCOMA; KIT; CARDIOTOXICITY;
D O I
10.1002/jso.21930
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastrointestinal stromal tumor (GIST), the most common sarcoma arising in the gastrointestinal tract, typically expresses the tyrosine-kinase receptor, C-KIT, and contains activating mutation in the c-kit or platelet-derived growth factor receptor (pdgfr) gene. Recently, development of small molecules that inhibit the kinase activity of mutant C-KIT and PDGFR proteins has radically changed treatment and prognosis of patients diagnosed with advanced GIST as this molecularly "targeted" therapy has demonstrated remarkable high-level of activity in this disease. J. Surg. Oncol. 2011;104:888-895. (C) 2011 Wiley Periodicals, Inc.
引用
收藏
页码:888 / 895
页数:8
相关论文
共 46 条
[1]   Inherited Predisposition to Gastrointestinal Stromal Tumor [J].
Agarwal, Rinki ;
Robson, Mark .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (01) :1-+
[2]   NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic and genotypic characteristics [J].
Andersson, J ;
Sihto, H ;
Meis-Kindblom, JM ;
Joensuu, H ;
Nupponen, N ;
Kindblom, LG .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (09) :1170-1176
[3]   Surgical resection of gastrointestinal stromal tumors after treatment with imatinib [J].
Andtbacka, Robert H. I. ;
Ng, Chaan S. ;
Scaife, Courtney L. ;
Cormier, Janice N. ;
Hunt, Kelly K. ;
Pisters, Peter W. T. ;
Pollock, Raphael E. ;
Benjamin, Robert S. ;
Burgess, Michael A. ;
Chen, Lei L. ;
Trent, Jonathan ;
Patel, Shreyaskumar R. ;
Raymond, Kevin ;
Feig, Barry W. .
ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (01) :14-24
[4]   Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment [J].
Berthet, B ;
Sugarbaker, TA ;
Chang, D ;
Sugarbaker, PH .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (03) :413-419
[5]   Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT [J].
Blanke, Charles D. ;
Demetri, George D. ;
von Mehren, Margaret ;
Heinrich, Michael C. ;
Eisenberg, Burton ;
Fletcher, Jonathan A. ;
Corless, Christopher L. ;
Fletcher, Christopher D. M. ;
Roberts, Peter J. ;
Heinz, Daniela ;
Wehre, Elisabeth ;
Nikolova, Zariana ;
Joensuu, Heikki .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :620-625
[6]   Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033 [J].
Blanke, Charles D. ;
Rankin, Cathryn ;
Demetri, George D. ;
Ryan, Christopher W. ;
von Mehren, Margaret ;
Benjamin, Robert S. ;
Raymond, A. Kevin ;
Bramwell, Vivien H. C. ;
Baker, Laurence H. ;
Maki, Robert G. ;
Tanaka, Michael ;
Hecht, J. Randolph ;
Heinrich, Michael C. ;
Fletcher, Christopher D. M. ;
Crowley, John J. ;
Borden, Ernest C. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :626-632
[7]  
Blay JY, 2007, J CLIN ONCOL, V25, P1107, DOI 10.1200/JCO.2006.09.0183
[8]   Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients [J].
Braconi, C. ;
Bracci, R. ;
Bearzi, I. ;
Bianchi, F. ;
Sabato, S. ;
Mandolesi, A. ;
Belvederesi, L. ;
Cascinu, S. ;
Valeri, N. ;
Cellerino, R. .
ANNALS OF ONCOLOGY, 2008, 19 (07) :1293-1298
[9]   Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib [J].
Chu, Tammy F. ;
Rupnick, Maria A. ;
Kerkela, Risto ;
Dallabrida, Susan M. ;
Zurakowski, David ;
Nguyen, Lisa ;
Woulfe, Kathleen ;
Pravda, Elke ;
Cassiola, Flavia ;
Desai, Jayesh ;
George, Suzanne ;
Morgan, Jeffrey A. ;
Harris, David M. ;
Ismail, Nesreen S. ;
Chen, Jey-Hsin ;
Schoen, Frederick J. ;
Van den Abbeele, Annick D. ;
Demetri, George D. ;
Force, Thomas ;
Chen, Ming Hui .
LANCET, 2007, 370 (9604) :2011-2019
[10]   PDGFRA mutations in gastrointestinal stromal tumors: Frequency, spectrum and in vitro sensitivity to imatinib [J].
Corless, CL ;
Schroeder, A ;
Griffith, D ;
Town, A ;
McGreevey, L ;
Harrell, P ;
Shiraga, S ;
Bainbridge, T ;
Morich, J ;
Heinrich, MC .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (23) :5357-5364